Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Zhixian Wu"'
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Natural stilbenes have shown significant potential in the prevention and treatment of diseases due to their diverse pharmacological activities. Here we present a mild and effective Ti-catalyzed intermolecular radical-relay [2σ + 2π] cycloa
Externí odkaz:
https://doaj.org/article/eefd8b849c6940158593bec75cebc880
Autor:
Zhongyuan Cui, Ling Du, Jielong Wang, Zhongzhuan Li, Jiehong Xu, Shiyu Ou, Dongliang Li, Shasha Li, Hanfang Hu, Gang Chen, Zhixian Wu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background In our previous study it was found that CENPL was overexpressed in hepatocellular carcinoma and significantly predicted patient's prognosis. However, the expression and prognostic value of CENPL in other gastrointestinal tumors re
Externí odkaz:
https://doaj.org/article/7459e5f43d9e455fbebb46c06ee9a09f
Autor:
Yi Li, Zhufu Shen, Xiao Jiang, Yuanyuan Wang, Zuozhang Yang, Yuchi Mao, Zhixian Wu, Gaofeng Li, Hong Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-16 (2022)
Abstract Background Radiation-induced lung fibrosis (RILF) is a common complication of thoracic radiotherapy. Alveolar epithelial cells play a crucial role in lung fibrosis via epithelial-mesenchymal transition (EMT). Exosomes derived from mesenchyma
Externí odkaz:
https://doaj.org/article/e5c202516376426ead837f1883d4bcdf
Autor:
Xia Zhang, Lirong Cai, Jian Fang, Fengsui Chen, Fan Pan, Kun Zhang, Qian Huang, Yuju Huang, Dongliang Li, Lizhi Lv, Man Chen, Ruiying Yan, Yanhua Lai, Yonghai Peng, Zhixian Wu
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
ObjectivesTo explore the benefit and safety of transarterial chemoembolization (TACE) in combination with sorafenib in patients with recurrent hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT).MethodsIn this multi-center ret
Externí odkaz:
https://doaj.org/article/4a1ccab9394148fabb58b7906153b75f
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundPatients with hepatocellular carcinoma (HCC) have poor prognosis, especially in advanced stages. Targeted therapy is the main treatment for advanced HCC patients, but the optimal targets for HCC remain poorly understood. The main purpose of
Externí odkaz:
https://doaj.org/article/d209b29dfd744186bdeb511312e2f907
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 22, Iss 3, Pp 799-805 (2021)
Metabolic Syndrome (MS) remains the leading cause of mortality and morbidity globally. Adipose tissue releases adipokines that play key roles in metabolic and cardio-cerebro-vascular homeostasis. Subfatin, induced after exercise or upon cold exposure
Externí odkaz:
https://doaj.org/article/c3a0a43e37d046a8b75747b3f9b3faa7
Autor:
Linbin Lu, Lujun Shen, Zhixian Wu, Yanhong Shi, Peifeng Hou, Zengfu Xue, Cheng Lin, Xiong Chen
Publikováno v:
EClinicalMedicine, Vol 47, Iss , Pp 101391- (2022)
Summary: Background: α-fetoprotein (AFP) response has been proven a key tumor marker for hepatocellular carcinoma (HCC), but its definition remains controversial. This study aims to characterize AFP trajectories after transarterial chemoembolization
Externí odkaz:
https://doaj.org/article/c55293515b764c6aaca61119814286d2
Autor:
Zhongyuan Cui, Ling Du, Jielong Wang, Zhongzhuan Li, Jiehong Xu, Shiyu Ou, Dongliang Li, Shasha Li, Hanfang Hu, Gang Chen, Zhixian Wu
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/f4f0c904f40a43c38c6250bfc0e74671
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe selection criteria for hepatic resection (HR) in intermediate-stage (IM) hepatocellular carcinoma (HCC) are still controversial. We used real-world data to evaluate the overall survival (OS) in treatment with HR or transarterial chemoem
Externí odkaz:
https://doaj.org/article/d19d7020d113421ab4505fbbe3122ec9
Autor:
Xiong Chen, Jingnan Liu, Linbin Lu, Zhimin Su, Peichan Zheng, Zhixian Wu, Huimin He, Shan Lin
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Objectives To explore the non-linear relationship between platelet count (PLT) and hepatocellular carcinoma (HCC) overall survival (OS).Setting The study was done in Sun Yat-sen University Cancer Center (SYSUCC) from January 2007 to May 2012, a total
Externí odkaz:
https://doaj.org/article/e625f2efb1964fdfaff2135cbdce217a